Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease
about
Non-alcoholic fatty liver disease: what the clinician needs to know.Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasisNon-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?Liver steatosis in hepatitis C patientsFructose as a key player in the development of fatty liver diseaseEffects of exercise training on intrahepatic lipid content in humansHigh fat feeding induces hepatic fatty acid elongation in mice.Homocysteine Induces Hepatic Steatosis Involving ER Stress Response in High Methionine Diet-Fed MiceFatty liver disease in children: eat now pay later.Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease.A new antidiabetic compound attenuates inflammation and insulin resistance in Zucker diabetic fatty rats.Nonalcoholic fatty liver disease and polycystic ovary syndrome.Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease.Genetic determinants of hepatic steatosis in man.Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategiesBinge alcohol consumption aggravates oxidative stress and promotes pathogenesis of NASH from obesity-induced simple steatosis.A high-dose Shiitake mushroom increases hepatic accumulation of triacylglycerol in rats fed a high-fat diet: underlying mechanism.Fructose consumption during pregnancy and lactation induces fatty liver and glucose intolerance in rats.Dietary trans-10, cis-12-conjugated linoleic acid alters fatty acid metabolism and microbiota composition in mice.Hepatoprotective effect of herb formula KIOM2012H against nonalcoholic fatty liver disease.Lipidomic Profiling of Liver Tissue from Obesity-Prone and Obesity-Resistant Mice Fed a High Fat DietEstrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance.Associations of insulin resistance, inflammation and liver synthetic function with very low-density lipoprotein: The Cardiovascular Health Study.Anthropometric Indices in Adults: Which Is the Best Indicator to Identify Alanine Aminotransferase Levels?Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease.Rosiglitazone and bezafibrate modulate gene expression in a rat model of non-alcoholic fatty liver disease--a historical prospectiveMechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies.PPARgamma in the endothelium regulates metabolic responses to high-fat diet in miceFactors underlying the association of body mass index with serum ALT in Chinese hypertensive adults without known hepatic diseasesFatty Acid Transport Proteins: Targeting FATP2 as a Gatekeeper Involved in the Transport of Exogenous Fatty Acids.Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment.Personal model-assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD.Steatosis in the liver.Acetaminophen-induced liver injury in obesity and nonalcoholic fatty liver disease.Nonalcoholic steatohepatitis and insulin resistance in childrenA Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease.Enhanced endoplasmic reticulum SERCA activity by overexpression of hepatic stimulator substance gene prevents hepatic cells from ER stress-induced apoptosis.Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.The anti-TNF-α antibody infliximab inhibits the expression of fat-transporter-protein FAT/CD36 in a selective hepatic-radiation mouse modelβ-Caryophyllene attenuates palmitate-induced lipid accumulation through AMPK signaling by activating CB2 receptor in human HepG2 hepatocytes.
P2860
Q24563068-58860566-19FB-47BF-B164-73691B21587AQ24608930-2036B543-CF14-41E0-9DA1-FEE48CFAF2EDQ27006992-2CA21EE7-834D-4F26-A1DC-6F38D2EDE58AQ27010631-66F103C5-4D9F-4565-8B8A-4FA99D69D163Q27014596-B2E97AFD-B114-4EE9-84F2-27FB0E5BC0D4Q28071597-7A36F21E-0406-415E-A706-563471D2FD8EQ33474784-6E4943D2-AEF2-4A6A-89ED-0EB6F471816DQ33616674-000FF3AF-CD0C-4B1A-A705-2381013911B8Q33718945-8021922C-ADD2-46AD-A003-83E82730E7CDQ33810241-AD2BA729-760C-489E-AA72-A01978BCB7D1Q33840323-058BF5D2-8F2E-4882-AA64-74DB12C499DAQ33886930-9B05E0F7-1845-4EAF-B341-7C357CC7B29AQ33891750-C77EE435-C31E-426C-A77B-1BC775A3FFB2Q34646183-B3EEBACD-3167-4964-BECF-733F16BC0339Q34657286-AA66780B-2EC0-49EF-A6C9-2A2008381EC4Q34777499-75EC8E2A-54CA-4023-8EBC-90AC1DD69510Q35102399-9929C699-0001-4D82-858E-FCA827F0EE74Q35239682-BDC8CC29-2625-41EE-90FA-9C9AC7D53842Q35564160-B912A01C-C357-46B3-A285-540BE1CC7221Q35585907-1269E70A-C42A-4B03-9B1C-17B6BAB22BFAQ35848129-544EE6BF-20EF-46C0-9381-8DDF99F79181Q36560629-DB4DFDB2-F3E9-49C5-8149-B8F1C02428AEQ36599680-B7AB97E2-9854-426A-A40C-D068BBC80133Q36633948-7C885D25-FC2A-441A-AB1B-879135D0CD2AQ36747795-AFDF9C6C-78FA-458C-B6D4-D742F4A6B38AQ36814812-9A862A9B-1CEE-4F1E-A5E0-6E7CFCEE0106Q36833317-E73EB3A5-2E09-40D9-BA8D-901ECC2E93F2Q37036060-774C30D4-A146-461F-A135-56771C4995E8Q37076624-0C1E30C1-4589-471C-B9F0-76C87BCF2296Q37102291-F021DFC6-6A7D-4F23-AC1C-E8D4A9AD5302Q37375539-30CA082F-E19F-42AE-A014-C6795E6CF370Q37727707-BAD91212-010E-4B40-A636-6319BD508E99Q38165140-2F810EED-3193-4810-8ECA-AE5D00EF9AADQ38191681-029B8E83-EB33-4BD8-A1CE-A85BEAB472B8Q38290119-AFE2653B-958A-4790-BCE2-D51E4C31DC1DQ38675911-B48105A1-66A6-4C55-8802-D34975C07D39Q39053060-A58A3ACA-912D-4DAE-8AE5-B3C51A45FBBDQ39093948-B8CE1218-3DB9-4F21-9360-9BB684492099Q39553461-2575C534-79E8-46F0-BF84-065E27F72BCFQ39730050-61E1C9A8-B842-49C3-842C-9B8FE6320FAC
P2860
Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Contribution of adipose tissue ...... nalcoholic fatty liver disease
@en
Contribution of adipose tissue ...... nalcoholic fatty liver disease
@nl
type
label
Contribution of adipose tissue ...... nalcoholic fatty liver disease
@en
Contribution of adipose tissue ...... nalcoholic fatty liver disease
@nl
prefLabel
Contribution of adipose tissue ...... nalcoholic fatty liver disease
@en
Contribution of adipose tissue ...... nalcoholic fatty liver disease
@nl
P2860
P356
P1476
Contribution of adipose tissue ...... nalcoholic fatty liver disease
@en
P2093
Iichiro Shimomura
Shinji Tamura
P2860
P304
P356
10.1172/JCI24930
P407
P577
2005-05-01T00:00:00Z